Abstract
Cellular reprogramming consists of the conversion of differentiated cells into pluripotent cells; the so-called induced Pluripotent Stem Cells. iPSC are amenable to in vitro manipulation and, in theory, direct production of any differentiated cell type. Furthermore, iPSC can be obtained from sick individuals and subsequently used for disease modeling, drug discovery and regenerative treatments. iPSC production was first achieved by transducing, with the use of retroviral vectors, four specific transcription factors: Oct4, Klf4, Sox2 and c-Myc (OKSM), into primary cells in culture Takahashi and Yamanaka, (Cell 126(4):663–676, 2006). Many alternative protocols have since been proposed: repeated transfections of expression plasmids containing the four pluripotency-associated genes Okita et al. (Science 322(5903):949–953, 2008), lentiviral delivery of the four factors Sommer et al. (Stem Cells 27(3):543–549, 2009), Sendai virus delivery Fusaki et al. (Proceedings of the Japan Academy. Series B, Physical and Biological Sciences 85(8):348–362, 2009), removal of the reprogramming vectors by ‘piggyBac’ transposition Woltjen et al. (Nature 458(7239):766–770, 2009); Kaji et al. (Nature 458(7239):771–775, 2009), Cre-recombinase excisable viruses Soldner et al. (Cell 136(5):964–977, 2009), episomal vectors Yu et al. (Science 324(5928):797–801, 2009), cell-penetrating reprogramming proteins Zhou et al. (Stem Cells 4(5):381–384, 2009), mammalian artificial chromosomes Hiratsuka et al. (PLoS One 6(10):e25961, 2011) synthetically modified mRNAs Warren et al. (Scientific Reports 2:657, 2012), miRNA Anokye-Danso et al. (Cell Stem Cell 8(4):376–388, 2009); however, although some of these methods are commercially available, in general they still need to attain the reproducibility and reprogramming efficiency required for routine applications Mochiduki and Okita (Biotechnol Journal 7(6):789–797, 2012). Herein we explain, in four detailed protocols, the isolation of mouse and human somatic cells and their reprogramming into iPSC. All-encompassing instructions, not previously published in a single document, are provided for mouse and human iPSC colony isolation and derivation. Although mouse and human iPSC share similarities in the cellular reprogramming process and culture, both cell types need to be handled differently.
Similar content being viewed by others
References
Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663–676.
Okita, K., Nakagawa, M., Hyenjong, H., et al. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science, 322(5903), 949–953.
Sommer, C. A., Stadtfeld, M., Murphy, G. J., et al. (2009). Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells, 27(3), 543–549.
Fusaki, N., Ban, H., Nishiyama, A., Saeki, K., & Hasegawa, M. (2009). Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proceedings of the Japan Academy. Series B, Physical and Biological Sciences, 85(8), 348–362.
Woltjen, K., Michael, I. P., Mohseni, P., et al. (2009). PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 458(7239), 766–770.
Kaji, K., Norrby, K., Paca, A., et al. (2009). Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature, 458(7239), 771–775.
Soldner, F., Hockemeyer, D., Beard, C., et al. (2009). Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell, 136(5), 964–977.
Yu, J., Hu, K., Smuga-Otto, K., et al. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324(5928), 797–801.
Zhou, H., Wu, S., & Joo, J. Y. (2009). Generation of induced pluripotent stem cells using recombinant proteins. Stem Cells, 4(5), 381–384.
Hiratsuka, M., Uno, N., Ueda, K., et al. (2011). Integration-free iPS cells engineered using human artificial chromosome vectors. PLoS One, 6(10), e25961.
Warren, L., Ni, Y., Wang, J., & Guo, X. (2012). Feeder-free derivation of human induced pluripotent stem cells with messenger RNA. Scientific Reports, 2, 657.
Anokye-Danso, F., Trivedi, C. M., Juhr, D., et al. (2009). Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell, 8(4), 376–388.
Mochiduki, Y., & Okita, K. (2012). Methods for iPS cell generation for basic research and clinical applications. Biotechnol Journal, 7(6), 789–797.
Maherali, N., & Hochedlinger, K. (2008). Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell, 3(6), 595–605.
Kim, J. B., Sebastiano, V., Wu, G., et al. (2009). Oct4-induced pluripotency in adult neural stem cells. Cell, 136(3), 411–419.
Huangfu, D., Osafune, K., Maehr, R., et al. (2008). Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nature Biotechnology, 26(11), 1269–1275.
Ware, C. B., Wang, L., Mecham, et al. (2009). Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells. Cell Stem Cell, 4(4), 359–369.
Shi, Y., Do, J. T., Desponts, C., et al. (2008). A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell, 2(6), 525–528.
Esteban, M. A., Wang, T., Qin, B., et al. (2009). Vitamin C enhances the generation of mouse.
Zhao, Y., Yin, X., Qin, H., et al. (2008). Two supporting factors greatly improve the efficiency of human iPS cells generation. Cell Stem Cell, 3(5), 475–479.
Van den Boom, V., Kooistra, S. M., Boesjes, M., et al. (2007). UTF1 is a chromatin-associated protein involved in ES cell differentiation. The Journal of Cell Biology, 178(6), 913–924.
Pirrone, A., Hager, B., & Fleckman, P. (2005). Primary mouse keratinocyte culture. Methods in Molecular Biology, 289, 3–14.
Lichti, U., Anders, J., & Yuspa, S. H. (2008). Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice. Nature Protocols, 3(5), 799–810.
Schnabel, L. V., Abratte, C. M., Schimenti, J. C., et al. (2012). Genetic background affects induced pluripotent stem cell generation. Stem Cell Research & Therapy, 3(4), 30.
Takahashi, K., Okita, K., Nakagawa, M., & Yamanaka, S. (2007). Induction of pluripotent stem cells from fibroblast cultures. Nature Protocols, 2(12), 3081–3089.
Camarasa, M. V., Galvez, V. M., Brison, D. R., & Bachiller, D. (2012). Optimized protocol for derivation of human embryonic stem cell lines. Stem Cell Reviews and Reports, 8(3), 1011–1020.
Camarasa, M., Brison, D., Kimber, S. J., & Handyside, A. H. (2009). Naturally immortalised mouse embryonic fibroblast lines support human embryonic stem cell growth. Cloning and Stem Cells, 11(3), 453–462.
Swift, S., Lorens, J., Achacoso, P., & Nolan, G. P. (2001). Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293 T cell-based systems. Edited by John E.Coligan. Current Protocols in Immunology. Chapter 10, Unit 10.17C.
Aasen, T., & Belmonte, J. C. (2010). Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells. Nature Protocols, 5(2), 371–382.
Yang, X. J. (2001). Preparation of recombinant retroviruses. Methods in Molecular Medicine, 47, 171–190.
Morita, S., Kojima, T., & Kitamura, T. (2000). Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Therapy, 7(12), 1063–1066.
Klee, M., Pallauf, K., Alcalá, S., et al. (2009). Mitochondrial apoptosis induced by BH3-only molecules in the exclusive presence of endoplasmic reticular Bak. EMBO Journal, 28(12), 1757–1768.
Yu, S. S., Kim, J. M., & Kim, S. (2000). High efficiency retroviral vectors that contain no viral coding sequences. Gene Therapy, 7(9), 797–804.
Swift, S., Lorens, J., Achacoso, P., Nolan, G. P. (2001). Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293 T cell-based systems. Current Protocols in Immunology, Chapter 10, Unit 10.17C.
Yu, J., Vodyanik, M. A., Smuga-Otto, K., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318(5858), 1917–1920.
Ohnuki, M., Takahashi, K., Yamanaka, S. (2009). Generation and characterization of human induced pluripotent stem cells. Current Protocols in Stem Cell Biology, Chapter 4, Unit 4A.2.
Park, I. H., Lerou, P. H., Zhao, R., et al. (2008). Generation of human-induced pluripotent stem cells. Nature Protocols, 3(7), 1180–1186.
Stadtfeld, M., & Hochedlinger, K. (2010). Induced pluripotency: history, mechanisms, and applications. Genes & Development, 24(20), 2239–2263.
Aasen, T., Raya, A., Barrero, M. J., et al. (2008). Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nature Biotechnology, 26(11), 1276–1284.
Zhao, X. Y., Li, W., Lv, Z., et al. (2009). iPS cells produce viable mice through tetraploid complementation. Nature, 461(7260), 86–90.
Martins-Taylor, K., & Xu, R. H. (2012). Concise review: genomic stability of human induced pluripotent stem cells. Stem Cells, 30(1), 22–27.
Lund, R. J., Närvä, E., & Lahesmaa, R. (2012). Genetic and epigenetic stability of human pluripotent stem cells. Nature Reviews Genetics, 13(10), 732–744.
Nagy, A., Gertsenstein, M., Vintersten, K., Behringer, R. (2003). Manipulating the Mouse Embryo 3rd edition, Cold Spring Harbor Laboratory Press.
Nakagawa, M., Koyanagi, M., Tanabe, K., et al. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnology, 26(1), 101–106.
Bahnson, A. B., Dunigan, J. T., Baysal, B. E., et al. (1995). Centrifugal enhancement of retroviral mediated gene transfer. Journal of Virological Methods, 54(2–3), 131–143.
Acknowledgments
This work was supported by the MICINN-JDC and MICINN PLE2009-0091 and IPT-2011-1402-900000 grants. We are grateful to J.C. Izpisúa-Belmonte and T. Aasen from the Center of Regenerative Medicine in Barcelona (CRMB) for their help in establishing iPSC technology in our lab, as well as for the gift of human OKSM retroviral plasmids and Ecotropic Phoenix cells. We also thank S. Yamanaka for the gift of mouse OKSM retroviral plasmids, and M.V. Camarasa for technical advise on stem cell culture. We also thank the Balearic Islands University Institute for Biomedical Research (IUNICS) for the use of their facilities.
Conflict of interest
The authors declare no potential conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lorenzo, I.M., Fleischer, A. & Bachiller, D. Generation of Mouse and Human Induced Pluripotent Stem Cells (iPSC) from Primary Somatic Cells. Stem Cell Rev and Rep 9, 435–450 (2013). https://doi.org/10.1007/s12015-012-9412-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-012-9412-5